Martha Alvarado Ibarra, hematologist and coordinator of the Hematology Area and Hematology Graduate Program at Hospital Ángeles Lomas, presented a comprehensive overview of the recent advances in the Hematopoietic Progenitor Cell Transplant Program, marked by the reopening of the hospital's transplant unit. The specialist highlighted that this milestone consolidates the institution's capacity to perform highly complex procedures to international standards. In an exclusive interview with LaSalud.mx/Hematology.mx, she emphasized the significance of this achievement for the country's medical and academic community. Alvarado Ibarra detailed that this progress was accompanied by renowned national and international hematologists, whose participation reaffirms the program's collaborative outlook. The specialist explained that the center is achieving yields of over 5 million CD34 cells per kilogram of the recipient's body weight with viabilities close to 100%, exceeding the standards expected in international donation and transplant programs. She noted that the new infrastructure includes four rooms designed according to international FACT-JACIE guidelines, ensuring safety, quality, and regulatory compliance for patients undergoing transplants. Finally, the specialist invited colleagues dedicated to transplantation to consider this unit as a space for work and collaboration, whether to perform procedures directly or to refer patients. She reiterated that the hematology team at Hospital Ángeles Lomas operates continuously, 24 hours a day, and is comprised of professionals with extensive experience in managing highly complex cases.
Hospital Ángeles Lomas Modernizes Its Transplant Unit
Hospital Ángeles Lomas has unveiled its modernized transplant unit, capable of performing procedures to international standards. Specialists report high cell viability rates and invite colleagues to collaborate.
